Novartis Group Companies

 
Displaying 16 - 23 of 23 Jobs.
 
Principal Scientist - CADD
Emeryville, CA
The pay range for this position at commencement of employment is expected to be between $144,000 $216,000/year; however, while salary ranges are effective from 1/1/23 through 12/31/23, f...

AD, Access & Reimbursement NPS Radioligand Therapy Remote - Seattle WA
Seattle, WA
The pay range for this position at commencement of employment is expected to be between $174,400 and $261,600/year; however, while salary ranges are effective from 1/1/24 through 12/31/2...

Quality Assurance Operations Manager
Millburn, NJ
Provide QA oversight of production, engineering, and supply chain operations through review/approval of test records for batch release, SOPs, C of As (as applicable), CAPAs, Deviations,...

QA Operations Specialist- 2nd shift
Millburn, NJ
Shop floor oversight o Supports QA Operations programs especially related to batch release activities and shop floor programs which includes Visual Monitoring on Surprise, GEMBA walkthro...

Clinical Development Medical Director, Radioligand Imaging/Therapy
East Hanover, NJ
The pay range for this position at commencement of employment is expected to be between $257,600 $386,400/year; however, while salary ranges are effective from 1/1/24 through 12/31/24, f...

Sr Prin Clinical Data Scientist (Prog Data Mgr)
East Hanover, NJ
Provides DM leadership across assigned trial(s) and Program(s) ensuring strong DM representation across the CTT. Acts as an ambassador for CDAM across the organization, showcasing busine...

Global Program Clinical Head - Rheumatology
East Hanover, NJ
377209BR Global Program Clinical Head Rheumatology USA About the role The ideal location for this role is East Hanover, NJ, but remote work may be possible (there may be restrictions bas...

Director, Ethics Risk & Compliance Integrated Marketing Advisor
East Hanover, NJ
372600BR Director, Ethics Risk & Compliance Integrated Marketing Advisor USA About the role Bringing life changing medicines to millions of people, Novartis sits at the intersection of c...